Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 144.40
Bid: 144.60
Ask: 145.00
Change: -0.40 (-0.28%)
Spread: 0.40 (0.277%)
Open: 138.00
High: 145.00
Low: 138.00
Prev. Close: 144.80
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Elementis announces sale of Surfactants business

12 Dec 2017 07:00

RNS Number : 0583Z
Elementis PLC
12 December 2017
 

12 December 2017

Elementis plc announces sale of Surfactants businessfor a cash consideration of EUR 39 million

Elementis plc ("Elementis", or the "Company") announces today that it has entered into an agreement to sell its Surfactants business located in Delden, The Netherlands to Kolb Distribution AG ("Kolb") for a cash consideration of EUR 39 million, subject to working capital adjustments. Completion of the sale, which is subject to completion of employee consultation processes, receipt of regulatory clearances and other customary closing conditions, is expected in the first half 2018. The proceeds resulting from the sale will be used for general corporate purposes and towards debt reduction.

As previously announced, after a strategic review the Company decided that Surfactants did not fit with the Elementis Reignite Growth strategy, due to a lack of scale and material capital requirements, and a third party would be best positioned to develop the business.

In addition to all of the Surfactants products, the Delden facility also manufactures a limited range of products sold by the Specialty Products segment. As part of this transaction Elementis will enter into a long term supply agreement with Kolb for continued sourcing of products which will modestly impact the Specialty Products operating margin in 2018.

Paul Waterman, CEO of Elementis, said:

"After a competitive process, we are very pleased to have reached an agreement to sell our Surfactants business to Kolb. This action is consistent with our Reignite Growth strategy. By exiting Surfactants we not only generate cash, but eliminate a strategically disadvantaged business for us, simplify our supply chain and are free to reallocate material capital and internal resources to focus on higher margin growth opportunities.

 I would like to thank our colleagues in the Delden facility for their dedication, professionalism and service to our customers. I am confident that the agreement with Kolb presents an exciting opportunity for both companies and we look forward to working together".

Enquiries

James Curran, Elementis Investor Relations Tel: 020 7067 2994

Martin Robinson, Tulchan Tel: 020 7353 4200

 

Note: The Surfactants business comprises the Delden manufacturing facility in the Netherlands and includes 100 per cent of the shares in Elementis Specialties Netherlands BV. As at 31 December 2016, Elementis Specialties Netherlands BV generated profits before tax of EUR 9 million and as at 30 June 2017 had gross assets of EUR 70 million.

Kolb Distribution AG is a wholly-owned subsidiary of Kuala Lumpur Kepong Berhad, a company listed on the Main Market of Bursa Malaysia Securities Berhad with a market capitalisation of approximately $ 6.3 billion at the end of June 2017.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISUURNRBWAUARA
Date   Source Headline
3rd May 202411:46 amRNSHolding(s) in Company
1st May 202410:06 amRNSTotal Voting Rights
30th Apr 202411:36 amRNSResult of AGM
30th Apr 20247:00 amRNSFirst quarter trading update
29th Apr 202412:13 pmRNSResponse to open letter from Gatemore
12th Apr 202411:33 amRNSDirector/PDMR Shareholding
12th Apr 202411:28 amRNSDirector/PDMR Shareholding
9th Apr 20246:04 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSAnnual Financial Report & Notice of AGM
19th Mar 20243:02 pmRNSAdditional Listing
15th Mar 20241:00 pmRNSDirectorate Change
12th Mar 20244:38 pmRNSDirector/PDMR Shareholding
12th Mar 20244:33 pmRNSDirector/PDMR Shareholding
8th Mar 20245:56 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirectorate changes
7th Mar 20247:00 amRNSPreliminary results year ended 31 December 2023
1st Mar 20249:30 amRNSBlock listing Interim Review
18th Jan 20247:00 amRNSTrading Update
2nd Jan 20249:45 amRNSTotal Voting Rights
1st Dec 202310:46 amRNSTotal Voting Rights
30th Nov 20239:38 amRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNS2023 Capital Markets Day
1st Nov 20239:46 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSThird Quarter Trading Update
2nd Oct 20239:34 amRNSTotal Voting Rights
20th Sep 202312:09 pmRNSResponse to open letter from Franklin Templeton
12th Sep 20233:13 pmRNSDirector Declaration
8th Sep 20239:30 amRNSHolding(s) in Company
1st Sep 20239:49 amRNSBlock listing Interim Review
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing
14th Mar 20237:30 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.